- Home
- BYD vs CORT Comparison
BYD vs CORT Comparison
Compare BYD & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYD
- CORT
- Stock Information
- Founded
- BYD 1973
- CORT 1998
- Country
- BYD United States
- CORT United States
- Employees
- BYD N/A
- CORT N/A
- Industry
- BYD Hotels/Resorts
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- BYD Consumer Discretionary
- CORT Health Care
- Exchange
- BYD Nasdaq
- CORT Nasdaq
- Market Cap
- BYD 6.8B
- CORT 7.6B
- IPO Year
- BYD 1993
- CORT N/A
- Fundamental
- Price
- BYD $81.21
- CORT $69.88
- Analyst Decision
- BYD Buy
- CORT Strong Buy
- Analyst Count
- BYD 14
- CORT 4
- Target Price
- BYD $86.08
- CORT $139.00
- AVG Volume (30 Days)
- BYD 750.8K
- CORT 644.6K
- Earning Date
- BYD 10-23-2025
- CORT 10-29-2025
- Dividend Yield
- BYD 0.86%
- CORT N/A
- EPS Growth
- BYD 26.05
- CORT N/A
- EPS
- BYD 6.48
- CORT 1.11
- Revenue
- BYD $4,027,724,000.00
- CORT $716,080,000.00
- Revenue This Year
- BYD N/A
- CORT $30.62
- Revenue Next Year
- BYD N/A
- CORT $37.68
- P/E Ratio
- BYD $12.91
- CORT $62.97
- Revenue Growth
- BYD 6.40
- CORT 25.71
- 52 Week Low
- BYD $58.94
- CORT $37.82
- 52 Week High
- BYD $87.83
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- BYD 35.07
- CORT 46.50
- Support Level
- BYD $84.83
- CORT $67.32
- Resistance Level
- BYD $86.29
- CORT $74.79
- Average True Range (ATR)
- BYD 1.55
- CORT 2.32
- MACD
- BYD -0.56
- CORT 0.01
- Stochastic Oscillator
- BYD 7.02
- CORT 34.27
About BYD Boyd Gaming Corporation
Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.